Gerhard Boost
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
Papers in
-
- Rheumatoid Arthritis Research and Therapies 5
-
- Inflammatory mediators and NSAID effects 3
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Eugene J. Segre (5 shared papers)Richard Runkel (3 shared papers)Enrico Forchielli (3 shared papers)Melvin D. Chaplin (2 shared papers)Milan R. Henzl (1 shared paper)Robert Emrie Smith (1 shared paper)Edward T. Tyler (1 shared paper)Sanford H. Roth (1 shared paper)
- Journals
- Scandinavian Journal of Rheumatology (2 papers)The Journal of Clinical Pharmacology (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Chemical and Pharmaceutical Bulletin (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
Gerhard Boost
10 papers receiving 271 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 75
- Pharmacology 112
- Pharmaceutical Science 49
- Rheumatology 43
- Analytical Chemistry 33
Countries citing papers authored by Gerhard Boost
This map shows the geographic impact of Gerhard Boost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Boost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Boost more than expected).
Fields of papers citing papers by Gerhard Boost
This network shows the impact of papers produced by Gerhard Boost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Boost. The network helps show where Gerhard Boost may publish in the future.
Co-authors
The 14 scholars most cited alongside Gerhard Boost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 154 | |
| 2 | 1972 | 81 | |
| 3 | 1973 | 45 | |
| 4 | 1972 | 36 | |
| 5 | 1975 | 29 | |
| 6 | 1973 | 23 | |
| 7 | 1973 | 10 | |
| 8 | [Clinical-pharmacological and pharmacokinetic studies with naproxen]. | 1975 | 6 |
| 9 | Methoxypropriocin (RS-3540); clinical study on 40 patients suffering from rheumatoid arthritis. | 1973 | 4 |
| 10 | [Long-term therapy of progressive chronic polyarthritis with naproxen]. | 1975 | 2 |
About Gerhard Boost
Gerhard Boost is a scholar working on Rheumatology, Pharmacology, Pharmacology, Pharmaceutical Science and Statistics and Probability, having authored 10 papers that have together received 390 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (5 papers), Inflammatory mediators and NSAID effects (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug Solubulity and Delivery Systems (1 paper), Menstrual Health and Disorders (1 paper), Statistical Methods in Clinical Trials (1 paper), Reproductive System and Pregnancy (1 paper) and Reproductive Biology and Fertility (1 paper). The work is most often cited by research in Pharmacology (75 citations), Pharmacology (112 citations), Pharmaceutical Science (49 citations), Rheumatology (43 citations) and Analytical Chemistry (33 citations). Gerhard Boost has collaborated with scholars based in Canada and United States. Frequent co-authors include Eugene J. Segre, Richard Runkel, Enrico Forchielli, Melvin D. Chaplin, Milan R. Henzl, Robert Emrie Smith, Edward T. Tyler, Sanford H. Roth, Hilli Sevelius and André Lussier. Their work appears in journals such as Scandinavian Journal of Rheumatology, The Journal of Clinical Pharmacology, The Journal of Clinical Endocrinology & Metabolism, Chemical and Pharmaceutical Bulletin and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.